What is Tonix Pharmaceuticals Holding EBIT per Share?
Tonix Pharmaceuticals Holding's EBIT per Share for the
three
months ended in Mar. 2024 was $-0.26.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-5.31.
During the past 3 years, the average EBIT per Share Growth Rate was 59.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 78.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Tonix Pharmaceuticals Holding's EBIT per Share or its related term are showing as below:
TNXP'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 59.8 Med: 83.4 Max: 90
Current: 59.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Tonix Pharmaceuticals Holding was 90.00% per year. The lowest was 59.80% per year. And the median was 83.40% per year.
TNXP's 3-Year EBIT Growth Rate is ranked better than 95.79% of 1305
companies
in the Biotechnology industry
Industry Median: 3.6
vs TNXP: 59.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Tonix Pharmaceuticals Holding EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.31
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tonix Pharmaceuticals Holding (NAS:TNXP) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Tonix Pharmaceuticals Holding EBIT per Share Related Terms
Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Tonix Pharmaceuticals Holding (Tonix Pharmaceuticals Holding) Business Description
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNXP has been successfully added to your 